1Ranson M,Tian Z,Andronicos NM,et al.In vitro cytotoxicity of bismuth-213(213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells[J].Breast Cancer Res Treat,2002,71(2):149-159.
2Liang WC,Sickle BJ,Nims TA,et al.Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node[J].Am J Surg,2001,182(4):365-368.
3Felton T,Harris GC,Pinder SE,et al.Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1[J].Breast,2004,1(3):35-41.
5Widt-Levert L,Tjan-Heijnen V,Bult P,et al.Stage migration in breast cancer:surgical decisions concerning isolated tumour cells and micrometases in the sentinel lymph node[J].Eur J Surg Oncol,2003,29(3):216-220.
6den Bakker MA,van Weeszenberg A,de Kanter AY,et al.Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometasis;too early to abandon axillary clearance[J].J Clin Pathol,2002,55(12):932-935.
7Noguchi M.Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes[J].Br J Surg,2002,89(12):1505-1515.
8Sachdev U,Murphy K,Derzie A,et al.Pre2dictors of nonsentinel lymph node metastasis inbreast cancer patinents[J].J Surg,2002,183(2):213-217.
9Slade MJ,Smith BM,Sinnett HD,et al.Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer[J].J Clin Oncol,1999,17(3):870-879.
10Stephan B,Florian D,Bjorn N,et al.A pooled analysis of bone marrow micrometastasis in breast cancer[J].N Engl J Med,2005,353(8):793-802.
二级参考文献22
1Bundred NJ, Gomella LG. Prognostic and predictive factors in breast cancer[J]. Cancer Treat Rev, 2001, 27(3):137～142.
2Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells[J]. Cancer, 1996, 78(1):10～16.
3Miksicek RJ, Myal Y, Peter H, et al. Identification of a noval breast-an salivary gland specific,Mucin-like gene stong expressed in normal and tumor human mammar epitheliam [J]. Cancer Res,2002, 5(62):2736～2740.
4Peter D, Heider K-H, Sinn H-K, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v expression ,a new prognostic factor in human breast cancer [J]. Int J Cancer,1995, 60(4):471～477.
5Berois N, Varangot M, Aizen B, et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR [J]. EurJ Cancer, 2000, 36 (6):717～723.
6Stathopoulou A, Mavroudis D, Perraki M, et al. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers[J]. Anticancer Res, 2003, 23 (2C) :1883 ～ 1890.
7Bossolasco P, Ricci C, Farina G, et al. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene[J]. Cancer Detect Prev, 2002, 26(1): 60～63.
8Herrera Gayol A, Jothy S. Adhesion protein in biology of breast cancer: contribution of CD44[J]. Exp Mol Pathol, 1999, 66:149～156.
9Eltahir EM, Mallinson DS, Birnie GD, et al .Putative markers for the detection of breast carcinoma cells in blood [J]. Br J Cancer,1998, 77:1203～1207.
10Huvos AG,Hutter RVP,Berg JW.Significance of axillary micrometastases and micrometastases in mammary cancer[J].Ann Surg,1971,173:44-46.
